Last reviewed · How we verify
NCT05379283
Does Topical Lidocaine Decrease Sweat During Exercise in the Heat?
NA trial testing Lidocaine in Sweat Pore Closure in 10 participants. Completed in 15 September 2022.
15 September 2022
Quick facts
| Lead sponsor | San Diego State University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 10 |
| Start date | 15 May 2022 |
| Primary completion | 15 September 2022 |
| Estimated completion | 15 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Lidocaine — full drug profile →
- control
Conditions studied
- Sweat Pore Closure — all drugs for Sweat Pore Closure →
Sponsor
San Diego State University
Who can join
Adults 18 to 35, any sex, with Sweat Pore Closure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Subjects will walk on a treadmill at 3 mph and sweat will be collected from both forearms. One arm will be pretreated with topical lidocaine, and the other will act as the control.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05379283
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lidocaine
Trials testing the same drug.
- NCT07488832 — Intravenous Lidocaine Infusion in Lumbar Fusion Surgery · NA · recruiting
- NCT07445191 — Efficacy of Triamcinolone-Lidocaine Mix in Trigger Points Injection of Masseter Muscle: Double-blinded, Randomized Contr · Phase 2, PHASE3 · not yet recruiting
- NCT07422558 — Intravenous Nalbuphine Versus Lidocaine for Prevention of Propofol Injection Pain · NA · not yet recruiting
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07355049 — The Effect of Dexmedetomidine Versus Lidocaine on Emergence Agitation. · NA · not yet recruiting
Other San Diego State University trials
Trials by the same sponsor.
- NCT06900634 — Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partner · NA · not yet recruiting
- NCT07271290 — Preventing Noise Exposure in Farmworkers · NA · not yet recruiting
- NCT07010133 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 3) · NA · not yet recruiting
- NCT06753123 — Be Well at Work-Plus: A Depression and Physical Activity Intervention for Hospital Service Workers (Aim 2) · NA · not yet recruiting
- NCT06635642 — Auditory Research in Children Living With HIV Exposure-uninfected (ARCHIVE) · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05379283 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by San Diego State University
- Last refreshed: 29 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05379283.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing